Growth Stories With IBD
Avsnitt

Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here’s What Went Wrong.

Growth Stories With IBD
Dela

On this episode of Growth Stories, we take a look at the escalating rivalry between Novo Nordisk and Eli Lilly and how the Danish drugmaker lost its grip on the weight-loss drug market. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Investor's Business Daily. Innehållet i podden är skapat av Investor's Business Daily och inte av, eller tillsammans med, Poddtoppen.